Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse.

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Abstract Text:

Marie Stiborová,Volker M Arlt,Colin J Henderson,C Roland Wolf,Vera Kotrbová,Michaela Moserová,Jirí Hudecek,David H Phillips,Eva Frei,

Ellipticine is an antineoplastic agent, which forms covalent DNA adducts mediated by cytochromes P450 (CYP) and peroxidases. We evaluated the role of hepatic versus extra-hepatic metabolism of ellipticine, using the HRN (Hepatic Cytochrome P450 Reductase Null) mouse model, in which cytochrome P450 oxidoreductase (POR) is deleted in hepatocytes, resulting in the loss of essentially all hepatic CYP function. HRN and wild-type (WT) mice were treated i.p. with 1 and 10 mg/kg body weight of ellipticine. Multiple ellipticine-DNA adducts detected by (32)P-postlabelling were observed in organs from both mouse strains. Highest total DNA binding levels were found in liver, followed by lung, kidney, urinary bladder, colon and spleen. Ellipticine-DNA adduct levels in the liver of HRN mice were up to 65% lower relative to WT mice, confirming the importance of CYP enzymes for the activation of ellipticine in livers, recently shown in vitro with human and rat hepatic microsomes. When hepatic microsomes of both mouse strains were incubated with ellipticine, ellipticine-DNA adduct levels with WT microsomes were up to 2.9-fold higher than with those from HRN mice. The ratios of ellipticine-DNA adducts in extra-hepatic organs between HRN and WT mice of up to 4.7 suggest that these organs can activate ellipticine and that more ellipticine is available in the circulation. These results and the DNA adduct patterns found in vitro and in vivo demonstrate that both CYP1A or 3A and peroxidases participate in activation of ellipticine to reactive species forming DNA adducts in the mouse model used in this study.

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Publishing Authors By Initials

M Stiborová,VM Arlt,CJ Henderson,CR Wolf,V Kotrbová,M Moserová,J Hudecek,DH Phillips,E Frei,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Toxicology and applied pharmacology

VOLUME: 226

Page Numbers: 318-27

Journal Abbreviation: Toxicol. Appl. Pharmacol.

ISSN: 0041-008X

DAY: 26

MONTH: 09

YEAR: 2007

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 416575

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse.

AFFILIATION: Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 128 40 Prague 2, Czech Republic.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Toxicol Appl Pharmacol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse Related Publications

• Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.
• Colorectal and vaginal injuries in personal watercraft passengers.
• Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon?
• Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism.
• Dietary {alpha}-Lipoic Acid Supplementation Inhibits Atherosclerotic Lesion Development in Apolipoprotein E Deficient and Apolipoprotein E/Low-Density Lipoprotein Receptor Deficient Mice.
• Direct observation of the kinetically relevant site of CO hydrogenation on supported Ru catalyst at 700 K by time-resolved FT-IR spectroscopy.
• Epileptic seizures are temporally interdependent under certain conditions.
• Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity.
• Liquid chromatographic determination of a quaternary ammonium-steroidal type drug in plasma with post-column extraction.
• Mechanism of metal-independent decomposition of organic hydroperoxides and formation of alkoxyl radicals by halogenated quinones.
• Necessity of Screening of both the Nose and the Throat To Detect Methicillin-Resistant Staphylococcus aureus Colonization in Patients upon Admission to an Intensive Care Unit.
• Photochemical CO2 splitting by metal-to-metal charge-transfer excitation in mesoporous ZrCu(I)-MCM-41 silicate sieve.
• Plasmid-mediated AmpC {beta}-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland.
• Rapid and Reliable Diagnostic Algorithm for Detection of Clostridium difficile.
• Rapid determination of phenylalanine and tyrosine in urine and serum by HPLC with electrochemical detection.
• Relevance of the A1555G mutation in the 12S rRNA gene for hearing impairment in Austria.
• Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse.
• Simultaneous determination of glutathione, glutathione disulphide, paracetamol and its sulphur containing metabolites using HPLC and electrochemical detection with on-line generated bromine.
• Why clinical trials of vitamin E and cardiovascular diseases may be fatally flawed. Commentary on "The relationship between dose of vitamin E and suppression of oxidative stress in humans".
• [Allergic mechanisms in extrinsic asthma: some diagnostic and therapeutic possibilities (author's transl)]
• [Assessing infections in general practice]
• [International Federation of Clinical Chemistry and section of clinical chemistry of the International Union of Pure and Applied Chemistry]
• [Malignant hemangiopericytoma in the uterus]
• [Not Available.]
• [Not Available.]
• [On the duration of fixation of the most frequent fractures]
• [Palliative nursing. Quality of life facilities quality of dying]
• [Problems in fetal hypotrophy]
• [Prostatic hyperplasia]
• [Remarks on the metabolism of bilirubin and the physiopathology of jaundice]